Bioactive microbial metabolites.

The short history, specific features and future prospects of research of microbial metabolites, including antibiotics and other bioactive metabolites, are summarized. The microbial origin, diversity of producing species, functions and various bioactivities of metabolites, unique features of their chemical structures are discussed, mainly on the basis of statistical data. The possible numbers of metabolites may be discovered in the future, the problems of dereplication of newly isolated compounds as well as the new trends and prospects of the research are also discussed.

[1]  János Béahdy Recent developments of antibiotic research and classification of antibiotics according to chemical structure. , 1974 .

[2]  J. Gyimesi,et al.  Metabolites of gentamicin-producing Micromonospora species I. Isolation and identification of metabolites. , 1977, The Journal of antibiotics.

[3]  A L Demain,et al.  The natural functions of secondary metabolites. , 2000, Advances in biochemical engineering/biotechnology.

[4]  P. Proksch,et al.  Drugs from the seas – current status and microbiological implications , 2002, Applied Microbiology and Biotechnology.

[5]  Miklos Feher,et al.  Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..

[6]  D. Hughes,et al.  Diversifying microbial natural products for drug discovery , 2003, Applied Microbiology and Biotechnology.

[7]  R. Williamson,et al.  Mannopeptimycins, novel antibacterial glycopeptides from Streptomyces hygroscopicus, LL-AC98. , 2002, Journal of the American Chemical Society.

[8]  H. Hirota,et al.  Revised structure of tetrapetalone A and its absolute stereochemistry , 2003 .

[9]  X. Ruan,et al.  A facile solid phase synthesis of tetramic acid. , 2003, Bioorganic & medicinal chemistry letters.

[10]  C. Gualerzi,et al.  Targets and assays for discovering novel antibacterial agents. , 2002, Journal of biotechnology.

[11]  D. Hill,et al.  Novel screen methodologies for identification of new microbial metabolites with pharmacological activity. , 1998, Advances in biochemical engineering/biotechnology.

[12]  M. Biabani,et al.  Advances in chemical studies on low‐molecular weight metabolites of marine fungi , 1999 .

[13]  Satoshi Omura,et al.  Trends in the search for bioactive microbial metabolites , 1992, Journal of Industrial Microbiology.

[14]  Nancy Torres,et al.  Synthesis and evaluation of ether and halogenated derivatives of mannopeptimycin glycopeptide antibiotics. , 2003, Bioorganic & medicinal chemistry letters.

[15]  B. Barrell,et al.  Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) , 2002, Nature.

[16]  U. Gräfe,et al.  General Aspects of Secondary Metabolism , 2001 .

[17]  N. Porter,et al.  Diversity of microbial products - discovery and application , 1993 .

[18]  K. Shin‐ya,et al.  Versipelostatin, a novel GRP78/Bip molecular chaperone down-regulator of microbial origin , 2002 .

[19]  Yoshiyuki Sakaki,et al.  Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis , 2003, Nature Biotechnology.

[20]  L. Lasure,et al.  Screening microbial metabolites for new drugs--theoretical and practical issues. , 1993, The Journal of antibiotics.

[21]  R. Alduina,et al.  Microbial technologies for the discovery of novel bioactive metabolites. , 2002, Journal of biotechnology.

[22]  A. Demain,et al.  Pharmaceutically active secondary metabolites of microorganisms , 1999, Applied Microbiology and Biotechnology.

[23]  J. Bérdy The discovery of new bioactive microbial metabolites: screening and identification , 1989 .